PU	O
.	O
1	O
and	O
C	O
/	O
EBP	O
(	O
alpha	O
)	O
synergistically	O
program	O
distinct	O
response	O
to	O
NF	O
-	O
kappaB	O
activation	O
through	O
establishing	O
monocyte	O
specific	O
enhancers	O
.	O


Unraveling	O
the	O
complexity	O
of	O
transcriptional	O
programs	O
coded	O
by	O
different	O
cell	O
types	O
has	O
been	O
one	O
of	O
the	O
central	O
goals	O
of	O
cell	O
biology	O
.	O


By	O
using	O
genome	O
-	O
wide	O
location	O
analysis	O
,	O
we	O
examined	O
how	O
two	O
different	O
cell	O
types	O
generate	O
different	O
responses	O
to	O
the	O
NF	O
-	O
kappaB	O
signaling	O
pathway	O
.	O


We	O
showed	O
that	O
,	O
after	O
TNF	O
-	O
alpha	O
treatment	O
,	O
the	O
NF	O
-	O
kappaB	O
p65	O
subunit	O
binds	O
to	O
distinct	O
genome	O
locations	O
and	O
subsequently	O
induces	O
different	O
subsets	O
of	O
genes	O
in	O
human	O
monocytic	O
THP	O
-	O
1	O
cells	O
versus	O
HeLa	O
cells	O
.	O


Interestingly	O
,	O
the	O
differential	O
p65	O
binding	O
in	O
two	O
cell	O
types	O
correlates	O
with	O
preexisting	O
cell	O
type	O
-	O
specific	O
enhancers	O
before	O
TNF	O
-	O
alpha	O
stimulation	O
,	O
marked	O
by	O
histone	O
modifications	O
.	O


We	O
also	O
found	O
that	O
two	O
transcription	O
factors	O
,	O
PU	O
.	O
1	O
and	O
C	O
/	O
EBPalpha	O
,	O
appear	O
to	O
synergistically	O
mediate	O
enhancer	O
creation	O
and	O
affect	O
NF	O
-	O
kappaB	O
target	O
selection	O
in	O
THP	O
-	O
1	O
cells	O
.	O


In	O
HeLa	O
cells	O
,	O
coexpression	O
of	O
PU	O
.	O
1	O
and	O
C	O
/	O
EBPalpha	O
conferred	O
TNF	O
-	O
alpha	O
responsiveness	O
to	O
a	O
subset	O
of	O
THP	O
-	O
1	O
-	O
specific	O
NF	O
-	O
kappaB	O
target	O
genes	O
.	O


These	O
results	O
suggest	O
that	O
the	O
diversity	O
of	O
transcriptional	O
programs	O
in	O
mammalian	O
cells	O
arises	O
,	O
at	O
least	O
in	O
part	O
,	O
from	O
preexisting	O
enhancers	O
that	O
are	O
established	O
by	O
cell	O
-	O
specific	O
transcription	O
factors	O
.	O
